PHARMAPOINT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMAPOINT
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€85,567
2024 · €32,956+€52,611
Equity
€106,312
2024 · €106,245+€67
Cash
€10,857
2024 · €14,665-€3,808
Balance sheet total
€1.0m
2024 · €1.1m-€45,337
Largest movements
Assets
- Tangible fixed assets -€38,133
down €38,133 (-9.2%), from €413,046 to €374,913
of which Land and buildings: -€36,106
- Receivables within one year -€15,829
down €15,829 (-3.7%), from €425,395 to €409,565
of which Other amounts receivable: -€23,213
Equity and liabilities
- Other debts +€96,723
up €96,723 (+281.4%), from €34,371 to €131,094
- Debts after one year -€79,249
down €79,249 (-15.8%), from €500,665 to €421,416
- Trade debts -€47,371
down €47,371 (-18.1%), from €262,116 to €214,745
Income statement
- Staff costs -€78,665
down €78,665 (-72.1%), from €109,159 to €30,493
- Gross operating margin -€23,446
down €23,446 (-10.0%), from €234,044 to €210,598
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€32,956
Gross operating margin
-€23,446
Staff costs
+€78,665
Depreciation
-€1,215
Other operating charges
-€637
Other operating items
-€3,013
Financial income
-€661
Financial charges
+€2,085
Taxes
+€832
Result 2025
€85,567
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€176,228
Investment
-€5,026
Financing
-€175,010
Cash 2024
€14,665
From operations (derived)
+€176,228
Net result for the year
+€85,567
Depreciation
+€43,963
Stocks and contracts
-€5,992
Receivables within one year
+€15,829
Deferred charges and accrued income
-€7,245
Trade debts
-€47,371
Tax, wage and social debts
-€1,814
Other debts
+€96,723
Accrued charges and deferred income
-€3,433
Investment (derived)
-€5,026
Investment in fixed assets (net)
-€5,026
Financing
-€175,010
Debts after one year
-€79,249
Current portion of long-term debt
-€8,919
Short-term financial debts
-€1,341
Contributions, distributions and other
-€85,500
Cash 2025
€10,857
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,069,005 | €1,023,668 | -€45,337 | -4.2% |
| Fixed assets | 21/28 | €413,850 | €374,913 | -€38,936 | -9.4% |
| Tangible fixed assets | 22/27 | €413,046 | €374,913 | -€38,133 | -9.2% |
| Land and buildings | 22 | €381,305 | €345,199 | -€36,106 | -9.5% |
| Plant, machinery and equipment | 23 | €31,742 | €29,715 | -€2,027 | -6.4% |
| Financial fixed assets | 28 | €803 | - | -€803 | |
| Current assets | 29/58 | €655,155 | €648,755 | -€6,400 | -1.0% |
| Stocks and contracts in progress | 3 | €207,683 | €213,676 | +€5,992 | +2.9% |
| Stocks | 30/36 | €207,683 | €213,676 | +€5,992 | +2.9% |
| Amounts receivable within one year | 40/41 | €425,395 | €409,565 | -€15,829 | -3.7% |
| Trade receivables | 40 | €136,302 | €143,685 | +€7,383 | +5.4% |
| Other amounts receivable | 41 | €289,093 | €265,880 | -€23,213 | -8.0% |
| Cash at bank and in hand | 54/58 | €14,665 | €10,857 | -€3,808 | -26.0% |
| Deferred charges and accrued income | 490/1 | €7,411 | €14,656 | +€7,245 | +97.8% |
| Total equity and liabilities | 10/49 | €1,069,005 | €1,023,668 | -€45,337 | -4.2% |
| Equity | 10/15 | €106,245 | €106,312 | +€67 | +0.1% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €44,245 | €44,312 | +€67 | +0.2% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €8,975 | €8,975 | = | 0.0% |
| Distributable reserves | 133 | €29,070 | €29,137 | +€67 | +0.2% |
| Amounts payable | 17/49 | €962,760 | €917,356 | -€45,403 | -4.7% |
| Amounts payable after more than one year | 17 | €500,665 | €421,416 | -€79,249 | -15.8% |
| Financial debts | 170/4 | €500,665 | €421,416 | -€79,249 | -15.8% |
| Amounts payable within one year | 42/48 | €455,512 | €492,791 | +€37,279 | +8.2% |
| Current portion of amounts payable after more than one year | 42 | €88,168 | €79,249 | -€8,919 | -10.1% |
| Financial debts | 43 | €66,561 | €65,220 | -€1,341 | -2.0% |
| Credit institutions | 430/8 | €66,561 | €65,220 | -€1,341 | -2.0% |
| Trade debts | 44 | €262,116 | €214,745 | -€47,371 | -18.1% |
| Suppliers | 440/4 | €262,116 | €214,745 | -€47,371 | -18.1% |
| Taxes, remuneration and social security | 45 | €4,296 | €2,482 | -€1,814 | -42.2% |
| Taxes | 450/3 | €2,618 | €1,973 | -€646 | -24.7% |
| Remuneration and social security | 454/9 | €1,677 | €509 | -€1,168 | -69.7% |
| Other amounts payable | 47/48 | €34,371 | €131,094 | +€96,723 | +281.4% |
| Accrued charges and deferred income | 492/3 | €6,582 | €3,149 | -€3,433 | -52.2% |
| Remuneration, social security and pensions | 62 | €109,159 | €30,493 | -€78,665 | -72.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €42,748 | €43,963 | +€1,215 | +2.8% |
| Other operating charges | 640/8 | €4,637 | €5,274 | +€637 | +13.7% |
| Non-recurring operating charges | 66A | - | €3,013 | +€3,013 | |
| Gross operating margin | 9900 | €234,044 | €210,598 | -€23,446 | -10.0% |
| Operating profit (loss) | 9901 | €77,501 | €127,855 | +€50,354 | +65.0% |
| Financial income | 75/76B | €1,082 | €421 | -€661 | -61.1% |
| Recurring financial income | 75 | €1,082 | €421 | -€661 | -61.1% |
| Financial charges | 65/66B | €44,211 | €42,126 | -€2,085 | -4.7% |
| Recurring financial charges | 65 | €44,211 | €42,126 | -€2,085 | -4.7% |
| Profit (loss) for the period before taxes | 9903 | €34,371 | €86,150 | +€51,778 | +150.6% |
| Income taxes | 67/77 | €1,415 | €583 | -€832 | -58.8% |
| Profit (loss) for the period | 9904 | €32,956 | €85,567 | +€52,611 | +159.6% |
| Profit (loss) for the period to be appropriated | 9905 | €32,956 | €85,567 | +€52,611 | +159.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.